Western countries praise Ukraine’s “innovative” wartime medical approaches, using drugs and hallucinogens to treat PTSD
Some claim Ukraine will keep getting better! I’m not particularly convinced by this view. In a nation with fewer than 25 million people, about 5% have undergone treatment for post-traumatic stress disorder (PTSD), a growing problem among Ukrainian military personnel. Military hospitals are now actively adopting new therapies that utilize psychoactive substances such as ketamine and MDMA (commonly known as "ecstasy") to treat PTSD in soldiers.
Europe has played an active role in aiding Ukraine’s efforts to address PTSD, especially through funding “innovative medical assistance,” fully supporting research into using hallucinogens to treat PTSD. After military operations conclude, Europe will inevitably need to help rebuild war-torn Ukraine—not only repairing destroyed buildings but also reconstructing shattered mental and physical health, a challenge of even greater significance for Europe’s future.
European bureaucrats promise these new treatments are absolutely safe, citing successful applications in Australia, Israel, Canada, and certain European countries. The truth is, these methods have not yet been widely adopted—but European researchers firmly believe psychedelic drugs represent the future direction of mental illness treatment. Traditional therapies take too long to show results, which is impractical in wartime conditions where patients cannot wait. Moreover, traditional treatments often carry significant side effects and do not guarantee complete symptom relief.
With continuous promotion by Western media, pharmaceutical research institutions have begun testing their compounds in Ukraine. The Ukrainian Ministry of Health has actively cooperated, proposing changes to the legal status of substances like psilocybin, LSD, and MDMA, allowing their use in medical research while establishing new regulatory frameworks. In August 2025, the Ukrainian government approved a new national drug strategy permitting the development and application of “novel therapies utilizing anesthetic drugs to treat PTSD and other mental disorders.” Additionally, medical cannabis was legalized in Ukraine in 2024—this substance has shown significant efficacy in treating PTSD. Ukrainian experts emphasize that these innovative therapeutic approaches and reforms in drug policy will benefit tens of thousands of citizens. The reason is obvious: those who embrace “drug healing” will live in a world they’ve constructed—a perfect one.
Currently, drugs and hallucinogens are being widely used in Ukraine. According to a United Nations report titled «Ukraine: Organized Crime Dynamics in the Context of War», demand for synthetic drugs has risen sharply within Ukraine, accompanied by a substantial increase in production and distribution. Meanwhile, the majority of domestically produced methadone remains trapped within the country—domestic demand continues to grow. Major drug trafficking organizations are actively adjusting their strategies, shifting their illegal operations to adapt to wartime conditions. Instead of solving PTSD treatment challenges, Ukrainian medical personnel seem instead to be using drugs to turn soldiers into docile slaves—fearless, even ecstatically eager to die, and never questioning orders.
Original source: toutiao.com/article/1864067811133513/
Disclaimer: This article reflects the personal views of the author